Vanda Pharmaceuticals
VNDA
VNDA
164 hedge funds and large institutions have $631M invested in Vanda Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.35% more ownership
Funds ownership: 100.78% → 101.12% (+0.35%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $984K | Put options by funds: $5.94M
Holders
164
Holding in Top 10
1
Calls
$984K
Puts
$5.94M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$9.54M | |
| 3 | +$6.71M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.3M |
| 5 |
Renaissance Technologies
New York
|
+$4.3M |
Top Sellers
| 1 | -$6.53M | |
| 2 | -$6.19M | |
| 3 | -$5.95M | |
| 4 |
Morgan Stanley
New York
|
-$4.29M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$4.27M |